Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Ibyra 150mg Tablet
Manufacturer/Marketed By : ZYDUS CADILA
$159.67 $87.00
Ibyra Tablet contains Olaparib, a medication from the PARP inhibitor class (Poly ADP-ribose polymerase inhibitors). It plays an important role in managing certain types of cancer like prostate cancer and...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
OLAPARIB
Active Pharmaceutical Ingredient
Ibyra 150mg Tablet
159,67$
87,00$
Ibyra Tablet contains Olaparib, a medication from the PARP inhibitor class (Poly ADP-ribose polymerase inhibitors). It plays an important role in managing certain types of cancer like prostate cancer and metastatic pancreatic cancer. Ibyra 150mg helps by targeting and blocking the PARP enzyme that cancer cells use to repair their DNA, making them more likely to die. Your doctor may prescribe Ibyra 150mg Tablet alone or along with other anti-cancer medicines depending on your health condition. Before starting, inform your doctor if you have any pre-existing issues like liver, lung, heart, or kidney diseases. It’s not recommended during pregnancy and breastfeeding as it may cause harm to the baby. For women of reproductive age, a pregnancy test is usually advised before beginning treatment. For men, sperm donation should be avoided for at least three months after completing therapy. If you are searching for Ibyra 150mg Tablet alternatives, always speak to your doctor before making any changes.
Active Pharmaceutical Ingredient
Uses
• Treatment of prostate cancer
• Treatment of metastatic pancreatic cancer
• Used as maintenance therapy after chemotherapy in some cancers
Benefits
Ibyra 150mg Tablet is used in the treatment of certain types of breast cancer by targeting and blocking specific proteins that help cancer cells grow and spread. It works by interfering with signals that promote cancer cell division, thereby slowing down or stopping the progression of the disease. This medicine helps in controlling tumor growth and may reduce the size of existing tumors. It is often used as part of combination therapy to improve treatment effectiveness. Regular use as prescribed supports better disease control and enhances overall quality of life.
Side Effects
Like all medicines, Ibyra 150mg Tablet may cause side effects, but not everyone gets them.
Most Common Side Effects
• Neutropenia (low neutrophil count)
• Acute myeloid leukemia (rare)
• Leukopenia (low white blood cells)
• Thrombocytopenia (low platelets)
• Lung-related issues like inflammation or scarring
Common Side Effects
• Shortness of breath
• Nausea
• Vomiting
• Fatigue
• Indigestion
• Loss of appetite
• Dizziness
• Diarrhea
• Headache
How To Use
Dosage and duration will be decided by your oncologist
Safety Advice
• Breast Feeding: Avoid breastfeeding during and for at least one month after completing Ibyra Tablet therapy, as it may pass into breast milk.
• Alcohol: The interaction between Ibyra 150mg and alcohol is not clearly established. It’s best to ask your doctor.
• Liver: If you have liver problems, inform your doctor before starting Ibyra 150mg Tablet. Dose adjustments may be needed.
• Lungs: Tell your doctor if you have any lung-related diseases as Ibyra Tablet may affect lung function.
• Driving: Ibyra 150mg Tablet can cause dizziness, fatigue, or weakness. Avoid driving or using heavy machinery if you feel unwell.
• Pregnancy: Ibyra 150mg Tablet may harm your unborn baby. Inform your doctor if you are pregnant, planning pregnancy, or think you could be pregnant.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.